Profound Medical Corp. (PROF) Tops Q2 EPS by 70c

Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of $0.35, $0.70 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $2.13 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
• Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
• Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance